Ghaziabad
Open Emergency Modal

Leukaemia Treatment in Ghaziabad

There are no characteristic signs of leukaemia as there are of other forms of cancer, as there are no palpable tumours. Leukaemia is detected when you undergo an ordinary blood test or when symptoms appear, which may resemble a persistent viral illness. The complexity of being diagnosed with leukaemia lies in the fact that "leukaemia" is not a single disease but several, each with distinct characteristics. This guide covers leukaemia, the different types of leukaemia, their symptoms, and treatment methods. You can get your entire treatment, from diagnostic tests to chemotherapy, targeted therapy, and bone marrow transplantation, right here in Ghaziabad by consulting the Hemato-Oncology department at Yashoda Medicity.

Blood Cancer Types: Where Leukaemia Fits  

Blood cancer is a general name for three categories of blood disease: leukaemia, lymphoma, and multiple myeloma. Leukaemia is a cancer of the blood-forming tissues that typically arises in the bone marrow. Lymphoma means cancer of the lymphatic system, which can be further classified as Hodgkin or non-Hodgkin lymphoma. Multiple myeloma represents cancer of plasma cells. The reason many symptoms of leukaemia are caused by a deficiency of normal blood components, rather than by a tumour pressing on something, is that leukaemia results in excessive production of abnormal white cells in the bone marrow.

Types Of Leukaemia  

Leukaemia is classified along two axes: how quickly it develops (acute vs. chronic) and which type of white blood cell it originates from (myeloid vs. lymphocytic). This gives four main types, and the distinction matters enormously — the four behave, and are treated, quite differently. 

  • Acute Myeloid Leukaemia (AML): Develops rapidly, is more common in adults (though it occurs at any age), and requires urgent treatment once diagnosed 
  • Acute Lymphoblastic Leukaemia (ALL): Also develops rapidly; the most common leukaemia in children, though it does occur in adults, where it tends to behave more aggressively than in children 
  • Chronic Lymphocytic Leukaemia (CLL): The most common leukaemia in adults overall, particularly older adults; typically slow-growing, and often discovered incidentally on a routine blood test long before symptoms appear 
  • Chronic Myeloid Leukaemia (CML): Historically slow-growing, associated with a specific genetic change (the Philadelphia chromosome); one of oncology's genuine treatment success stories, since targeted oral therapy has turned what was once a life-limiting diagnosis into a manageable chronic condition for most patients 

Leukaemia Symptoms  

As leukaemia interferes with normal blood cell production, almost all symptoms associated with the disease can be directly linked to either a lack of proper red blood cell, white blood cell or platelet levels:

  • Tiredness and paleness: Due to a lack of normal red blood cells (anaemia)
  • Frequent infections and fever episodes: Despite elevated levels of white blood cells, they do not fulfill their function in immune response
  • Easy bruising and bleeding: Bleeding gums, frequent nosebleeds or prolonged bleeding – due to low platelet level
  • Bone or joint pain: As a result of overcrowding of bone marrow with abnormal blood cells
  • Enlarged lymph glands or swelling in the area under left ribs due to enlarged spleen
  • Unexplained weight loss and night sweats

Symptoms of blood cancer in adults usually progress slowly and might be considered results of fatigue, stress or age-related changes – hence why even a standard blood test can lead to suspicions of leukaemia.

Leukaemia Rash: What It Looks Like  

The so-called “leukaemia rash” consists primarily of petechiae – small round red or purple spots formed as a result of minor bleeding under the skin and occurring in clusters, mostly on the lower limbs, although they may be present anywhere. The reason is that a lack of platelets makes small blood vessels more prone to leakage. Larger areas of discoloration resembling a bruise (purpura) develop in the same manner. Rarely, leukaemia cells invade the skin directly, leading to the formation of elevated firm nodules or plaques referred to as “leukaemia cutis” – a condition more common in some subgroups of AML.

AML Symptoms  

Because Acute Myeloid Leukaemia develops quickly, symptoms often build up over days to a few weeks rather than months: marked fatigue and breathlessness (from anaemia), fever and infections that don't resolve as expected, easy bruising or bleeding (including gum bleeding), bone pain, and sometimes the skin or gum changes described above. The speed of onset is itself a clue — AML tends to make people feel acutely unwell in a way that's noticeably different from their baseline, which is usually what prompts urgent medical evaluation. 

CLL Symptoms (Chronic Lymphocytic Leukaemia Symptoms)  

CLL, in many ways, is the reverse of this tale. In the majority of patients diagnosed with CLL, there are absolutely no symptoms at the time of diagnosis, and the diagnosis is made simply by a routine blood test showing high lymphocyte counts years before symptoms spontaneously manifest. The symptoms associated with CLL may be as follows:

  • Swelling of painless lymph nodes in the neck, armpit, or groin region.
  • Gradual onset of fatigue.
  • Weight loss without cause and night sweats.
  • Recurrent infections due to the progressive impairment of immune function.
  • Fullness in the left lower abdomen because of an enlarged spleen.

It is precisely for this reason that CLL is often monitored rather than treated immediately. More about this later.

Diagnosing Leukaemia  

  • CBC and peripheral blood smear: Usually the first evidence that there is a problem that requires more investigation
  • Bone marrow aspiration and biopsy: Mandatory procedures necessary for diagnosing the disease and determining its exact subtype
  • Flow cytometry: Determines the exact characteristics of the abnormal cells, which is crucial for proper typing of the disorder
  • Cytogenetic and molecular analysis: Determines the genetic abnormalities (like the Philadelphia chromosome in CML), which directly determine the treatment and prognosis

Leukaemia Survival Rate  

Leukaemia survival rates differ very widely depending on type, age at diagnosis, genetic or molecular risk category, and early response to treatment — average survival rates across a whole population may very well not apply to the individual case, and we would strongly advise you to consult your hematologist about the specifics of your prognosis instead of these generic numbers. However, as a general starting point:

  • CLL offers a relatively good prognosis, with a 5-year relative survival rate usually quoted in the high 80s (%), owing to its slow nature and the advances in modern targeted therapy
  • CML, once a life-threatening diagnosis, now enjoys a 5-year relative survival rate usually quoted above 70%, and, in patients undergoing modern targeted therapy, an average life expectancy that approaches normal life expectancy of the general population
  • ALL has a highly variable prognosis depending on age, with considerably higher rates in childhood compared to adulthood, and with a 5-year relative survival rate of 70% when all ages are taken into account
  • AML has the highest dependence on age and risk factors among the four, with a 5-year relative survival rate usually quoted around the low 30s (%) for all ages taken together, but ranging from much higher to much lower numbers depending on age and risk of a particular patient
  • These numbers represent population-level statistical data and are not prognostic for any individual patient. Genetic risk category, overall fitness, and response to initial treatment are usually of more importance.

Chemotherapy For Leukaemia  

Chemotherapy varies depending on the leukaemia subtype. In the cases of AML and ALL, intensive combination chemotherapy is the cornerstone of the treatment – usually induction therapy in order to induce remission, and then consolidation therapy (and for ALL also maintenance therapy), in order to prevent relapse. In the case of high-risk or relapsed acute leukaemia, it is often followed by an allogeneic stem cell transplant. 

In the case of CML, the use of chemotherapy has been overtaken in the frontline by the use of tyrosine kinase inhibitors, while more intensive regimens have been reserved for refractory and advanced phases. In the case of CLL, there have been recent changes regarding the use of targeted oral therapies and antibody-based therapy – in selected patients, the use of chemoimmunotherapy is still possible – a true discussion for the treatment of your CLL that your haematologist will discuss with you.

CLL Treatment  

As most cases of CLL develop slowly and may stay dormant for many years, asymptomatic and early-stage CLL are usually treated with surveillance ("watch and wait") instead of treatment right away – starting early treatment does not help patients who are not showing any signs of the disease, and delays possible side effects from the therapy. The treatment is applied when the disease causes symptoms or progresses – this means the development of symptoms such as poor blood values, enlarged lymph nodes or spleen, and general complaints (fever, weight loss). If treatment is needed, its selection is determined by the individual's CLL genetics, the patient's fitness, and previous treatments.

Blood Cancer Treatment: Beyond Chemotherapy  

  • Targeted Therapy: Personalized based on the genetic and molecular make-up of the leukaemia, which explains the importance of cytogenetic and molecular studies at diagnosis
  • Bone Marrow/ Stem Cell Transplantation: Autologous (patient’s own cells) or allogeneic (donor cells) depending on eligibility in high-risk or relapsed patients, enabled by advanced infection control facilities for both adults and children
  • Cell & Gene Therapy: Sophisticated cellular therapy approaches for selected relapsed and refractory patients, backed by an exclusive Cell & Gene Therapy Lab
  • Advanced Radiation & Precision Technologies: When radiation therapy or total body irradiation is indicated, advanced platforms are used to deliver extreme precision, including Varian ETHOS with HYPERSIGHT and IDENTIFY Technology, Varian EDGE with HyperArc and Brainlab ExacTrac Dynamic, Elekta Unity MR-Linac, and high-precision brachytherapy systems such as Varian Bravos. 
  • Supportive care: Blood transfusions, infection prevention and management, nutritional and psychological support in parallel with therapy

Why Choose Yashoda Medicity For Leukaemia Treatment In Ghaziabad  

  • Hemato-Oncology led by Dr. Nivedita Dhingra, Director & Head of Hematology, Hemato-Oncology and Bone Marrow Transplant (Adult & Paediatric), with Dr. Karuna Jha, Senior Consultant 
  • Full diagnostic pathway on-site — CBC, peripheral smear, bone marrow biopsy, flow cytometry and molecular/cytogenetic testing — for fast, accurate subtyping 
  • Day-care chemotherapy units for induction, consolidation and maintenance protocols 
  • Adult and paediatric Bone Marrow Transplant programme with a dedicated Cell and Gene Therapy Lab for advanced cases 
  • Every case reviewed by a multidisciplinary tumour board before a treatment plan is finalised 
  • Full pathway available locally in Ghaziabad, without needing to travel into central Delhi for diagnosis, chemotherapy or transplant follow-up 

Book a Consultation  

If a blood test has flagged an abnormal count, or you're experiencing persistent fatigue, unusual bruising, recurrent infections or unexplained swelling, an early haematology evaluation gives you the clearest picture of what's actually going on and the widest range of treatment options. To book a consultation with the Hemato-Oncology team at Yashoda Medicity, Ghaziabad, call +91 9266610101 or use the online booking form on this page. 

Yashoda Medicity: Yashoda Medicity, Hospital Plot, Shakti Khand 2, Indirapuram, Ghaziabad, Uttar Pradesh - 201014  |  Phone: +91 9266610101

Meet Our Expert Medical Team

Dr. Jigar Paghadar
Dr. Jigar Paghadar

Junior Consultant

Dr. Nikhil Tandon
Dr. Nikhil Tandon

Consultant

Dr. Nishtha Sachdeva
Dr. Nishtha Sachdeva

Consultant

Dr. Manish Singhal
Dr. Manish Singhal

Vice Chairman

Dr. Nivedita Dhingra
Dr. Nivedita Dhingra

Director & Head

Dr. Karuna Jha
Dr. Karuna Jha

Senior Consultant

Dr. Hemlata Garg
Dr. Hemlata Garg

Consultant

Dr. Ipshita Sahoo
Dr. Ipshita Sahoo

Associate Consultant

Dr. Satinder Kaur
Dr. Satinder Kaur

Senior Director and Head

Dr. Abhishek Yadav
Dr. Abhishek Yadav

Director

Dr. Gagan Saini
Dr. Gagan Saini

Vice-Chairman & Head

Dr. Rashmi Shukla
Dr. Rashmi Shukla

Principal Consultant

Our Technological Advancements

Patient Testimonials

Frequently Asked Questions

AML (Acute Myeloid Leukaemia) is a fast-growing cancer that requires immediate treatment, whereas CLL (Chronic Lymphocytic Leukaemia) usually develops slowly and is often detected incidentally during a blood test. Early-stage CLL may be managed with observation rather than immediate treatment.

A rash alone does not necessarily indicate leukaemia. However, small red or purple dots (petechiae), especially when accompanied by fatigue, unusual bruising, or recurrent infections, should prompt medical evaluation and blood tests because they may be associated with low platelet levels from various causes, including leukaemia.

No. Early-stage asymptomatic CLL is often managed with active surveillance rather than immediate treatment, as therapy may not provide additional benefit until symptoms or signs of disease progression develop.

The survival rate for AML varies significantly depending on factors such as patient age, overall health, genetic and molecular features of the leukaemia, and response to treatment. A haematologist can provide a more personalised outlook based on the individual diagnosis and risk profile.

Outcomes depend on the type of leukaemia. Chronic Myeloid Leukaemia can often be controlled long term with targeted therapy, many cases of Acute Lymphoblastic Leukaemia and some cases of AML can achieve long-term remission or cure, while Chronic Lymphocytic Leukaemia is usually managed over time with periods of treatment and observation.

Main Speciality


Speciality in Location